Press Releases

 

 
Press Releases
Date Title and Summary View
Nov 12, 2015 RANCHO CUCAMONGA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2015. Net revenues of $63.9 million for the third quarter GAAP net loss of $3.0 million, or $0.07 per diluted share for the ...
Nov 5, 2015 RANCHO CUCAMONGA, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2015 ended September 30, 2015, after the market closes on Thursday, November 12, 2015, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific...
Oct 20, 2015 RANCHO CUCAMONGA, Calif., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that it began shipping Amphadase® (hyaluronidase injection). This launch marks the first product made using starting material from the Company's subsidiary, ANP, located in Nanjing, China. ...
Aug 12, 2015 RANCHO CUCAMONGA, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2015. Net revenues of $53.9 million for the second quarter GAAP net loss of $6.6 million, or $0.15 per diluted share for the sec...
Aug 4, 2015 RANCHO CUCAMONGA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2015 ended June 30, 2015, after the market closes on Wednesday, August 12, 2015, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time...
Jun 22, 2015 RANCHO CUCAMONGA, Calif., June 22, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") announced today that the U.S. Food and Drug Administration ("FDA") granted approval of the Company's New Drug Application ("NDA") supplement for Amphadase® (hyaluronidase injection). This marks the first FDA ...
May 29, 2015 RANCHO CUCAMONGA, Calif., May 29, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies Healthcare Conference on Wednesday, June 3, 2015 at 10:00 a.m. Eastern Time in New York, NY. This presentation will be made available with a live webcast ...
May 13, 2015 RANCHO CUCAMONGA, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the first quarter ended March 31, 2015. Net revenues of $56.9 million for the first quarter GAAP net loss of $0.7 million, or $0.01 per diluted share for the first...
May 11, 2015 RANCHO CUCAMONGA, Calif., May 11, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell, President will be presenting at the Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 9:20 a.m. Pacific Time in Las Vegas, NV. This presentation will be made avail...
May 7, 2015 RANCHO CUCAMONGA, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its first quarter of 2015 ended March 31, 2015, after the market closes on Wednesday, May 13, 2015, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. ...
Page: FirstPrevious
3
NextLast
= add release to Briefcase

 

Copyright © 2017 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States